Exciting advances in GPCR-based drugs discovery for treating metabolic disease and future perspectives-Reference-Cited by-同舟云学术

Exciting advances in GPCR-based drugs discovery for treating metabolic disease and future perspectives

Author:

Quiñones Mar¹²,Fernø Johan³,Diéguez Carlos¹²,Nogueiras Ruben¹²,Al-Massadi Omar⁴⁵⁶

Affiliation:

1. Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain

2. CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Madrid, Spain

3. Hormone Laboratory, Haukeland University Hospital, Bergen, Norway

4. Neurotransmission et signalisation laboratoire, Inserm UMR-S 839, Paris, France

5. Faculté des Sciences et d’Ingénierie, Sorbonne Université, Paris, France

6. Institut du Fer a Moulin, Paris, France

Funder

the Centro de Investigación Biomédica en Red (CIBER) de Fisiopatología de la Obesidad y Nutrición

Ministerio de Economia y Competitividad

European Community Seventh Framework Programme

M.Q. is a recipient of a Postdoctoral contract from Galician Government

the Xunta de Galicia

Publisher

Informa UK Limited

Subject

Drug Discovery

Link

Reference143 articles.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献